T lymphocytes (pivotal in many inflammatory pathologies) are targets for glucocorticoid hormone
Introduction
GCs are commonly used as an immunosuppressive and antiinflammatory agent and they have several effects on T lymphocytes (1) . One prominent effect of GC on T cells is to induce cell death (2) . GC-induced cell death requires glucocorticoid receptor (GR)-mediated gene transactivation (1, 3) and can work via the mitochondria-dependent pathway on which many anti-apoptotic molecules such as Bcl-2, Bcl-XL and IAPs (inhibitors of apoptosis) act. GC can inhibit NF-jB, either directly or by I-jB upregulation, and thereby induce cell death. GC can also result in cell death indirectly by regulating prostaglandin synthesis and nitric oxide generation. Conversely, GC can also inhibit T-cell apoptosis, particularly activation-induced apoptosis, partly by inhibiting upregulation of FasL (2, 4) . Two molecules induced by GC may mediate this anti-apoptotic effect of GC. One is glucocorticoid-induced leucine zipper (GILZ) that blocks activation-induced FasL upregulation and subsequent apoptosis (5) . The other is the glucocorticoid-induced TNF receptor (GITR) (6) .
GITR was identified as a new member of the TNF receptor superfamily, by comparing gene expression in untreated and DEX-treated murine T-cell lines (6) . GITR can also be induced when Tcells are activated (6) . Although mouse GITR is induced by either GC engagement or T-cell activation, its human homologue (hGITR/AITR) is upregulated only by activation (7) . Therefore, the requirements for GR signaling in inducing GITR expression by T cells remain moot. Functionally, overexpression of GITR in T cell hybridomas inhibited activation-induced cell death but not death induced by apoptotic signals derived from Fas triggering, DEX treatment, or UV irradiation. Primary T cells from GITR-deficient mice were also more susceptible to activation-induced apoptosis than GITR wild-type T cells (8) . This evidence indicates that GITR was particularly critical for protection from activation-induced cell death. However, cell activation can also antagonize GC-mediated cell death (2) . The molecular basis for the interaction between GC-and activation-induced cell death pathway is still not clear and GITR could be the missing link.
GITR has received great attention recently because it is constitutively and exclusively expressed at high levels on CD25 + CD4 + regulatory T cells in naive mice (9, 10) , albeit that T-cell activation will result in GITR upregulation. Signaling through GITR was proposed to break self-tolerance (10 
CD4
+ and CD8 + cells in vitro (9). More importantly, removal of GITR-expressing T cells from transferred cells or administration of anti-GITR antibody resulted in autoimmune disease in animal models (10) . These findings point to a critical role for GITR in immune regulation. Given that CD25 + CD4 + cells induced by recent activation events are different from regulatory T cells that constitutively express CD25, it is plausible that the ontogeny of CD4 + cells that constitutively express GITR may be also different from activation-induced GITR + T cells. It remains untested whether T cells that constitutively express GITR can develop in the absence of GR signaling, considering that GITR was first identified as a GC-induced gene. Furthermore, it is also unclear whether this unique subset of CD4 + cells is a target of GC action.
A role for GC in T-cell development has been implicated from the work of Ashwell and colleagues (11) (12) (13) . Previously, we used GRÿ/ÿ reconstituted mice to investigate the role of GC in T-cell development and found that T-cell development and selection were unaffected by the absence of GR signaling (14, 15) , a result that has been confirmed by others using independently generated GRÿ/ÿ mice (16) . In the current study, we tested whether the development of GITR-expressing T cells requires GR signaling in GRÿ/ÿ mice. We then tested the regulation of GITR expression on T cells from GR+/+ and ÿ/ÿ mice by DEX and anti-CD3 stimulated activation in vitro and analyzed the interrelationship between GITR upregulation and cell fate including apoptosis, proliferation and cytokine production.
Methods

Mice
GR+/ÿ mice on a GRMB strain background were backcrossed to the C57BL/6 background greater than nine times.
Most GRÿ/ÿ mice die neonatally due to respiratory complications. Therefore, in some experiments, Rag1ÿ/ÿ mice reconstituted with fetal liver cells from GRÿ/ÿ and GR+/+ mice were used. To produce reconstituted mice, adult C57BL/6 GR+/ÿ mice were crossed to produce fetal GRÿ/ÿ mice. Fetal mice were removed 14 days after the detection of a plug and liver suspensions were prepared. Fetal tail tissue was genotyped by PCR. Six-to eight-week-old B6 Rag2ÿ/ÿ mice were irradiated with a dose of 4 Gy, and then injected with either GR+/+ or GRÿ/ÿ fetal liver cells intravenously after a further 2 h delay. Each recipient received at least 2 3 10 6 fetal liver cells. Blood samples were taken prior to sacrifice to confirm reconstitution. In rare cases, a few GRÿ/ÿ mice survive to adulthood and when available these were used in this study, together with age/sex-matched GR+/+ littermate.
Flow cytometry
Cell suspensions were prepared from the thymus, spleen and lymph nodes of mice in cold PBS containing 2% FCS, enumerated and stained with combinations of the following antibodies for 20 min at 4°C, before analysis on either one laser, three color FACScan (BD Biosciences, Palo Alto, CA) or a two-laser, four-color LSR (BD Biosciences): anti-CD4 (clone RM4-5), anti-CD8 (clone 53-6.7), anti-T-cell receptor (TCR)ab (clone H57-597), anti-CD62L (clone MEL-14), anti-CD44 (clone IM7), anti-CD25-PE (clone PC61) (all antibodies were purchased from BD Biosciences). Anti-GITR mAb was kindly provided by Professor S. Sakaguchi (Kyoto University, Japan) and was biotinylated in our laboratory. Unconjugated rat antimouse CD16 (2.4G2 clone) was used during flow cytometry to block non-specific FcR-mediated binding.
Cell culture
Sterile lymphocytes were isolated and in some instances labeled with CFSE (Molecular Probes, Eugene, OR) by incubation at 10 3 10 ÿ6 cells/ml in 5 lM CFSE for 10 min at 37°C, followed by two washes in PBS containing 1% BSA. Cells were cultured at 5 3 10 6 /ml in DMEM (Life Technologies Inc., Rockville, MD), 10% FCS (CSL, Melbourne, Australia), 2 mM GlutaMax (Life Technologies Inc.) and 50 lg/ml penicillin/ streptomycin (Life Technologies Inc.) with either 10 ÿ8 to 10 ÿ6 M DEX (Sigma, St Louis, MO), 10 lg/ml immobilized anti-CD3, or both, for 1-4 days. Cultured cells were stained for CD4, CD8 and GITR. The numbers of cell divisions after days 1-4 were determined by the intensity of the CFSE fluorescence.
T-cell enrichment
Lymph node cells were prepared from pooled lymph nodes of four GR+/+ and GRÿ/ÿ mice. Lymph node cells were stained with PE-conjugated anti-CD8 antibody. Stained cells after washing were incubated on ice with anti-PE microbeads for 15 min. Washed cells were applied to autoMACS (Miltenyi Biotec, Germany) and CD8 + -enriched cells were positively selected. Purity of the enriched population after double passage through the column was generally >98%.
Apoptosis assay
DEX-induced apoptosis of lymphocytes was measured with a well established method (17) . Briefly, the cells were harvested from cultures and washed once with 2% FCS-PBS. Cells were then resuspended in 1 ml hypotonic propidium iodide (PI) solution (50 lg/ml in 0.1% sodium citrate and 0.1% Triton-100, Sigma). The cells were placed at 4°C in the dark overnight before flow cytometric analysis.
PCR and Southern blotting analysis
Genotyping of mice at the GR gene locus by PCR or Southern blot analysis was performed as previously described (14, 15) except that a 32 P-labeled riboprobe was generated from the 1.4 kb HindIII genomic fragment using a Riboprobe kit (Promega, Madison, WI).
Results
Differential regulation of GITR expression by T cells in response to anti-CD3 and DEX in GR+/+ and GRÿ/ÿ mice
Because GRÿ/ÿ mice do not generally survive postnatally due to respiratory insufficiency, chimeric mice were generated whereby irradiated Rag-deficient mice were repopulated with GRÿ/ÿ or GR+/+ littermate fetal liver cells. Groups of mice were screened at 6-12 weeks following reconstitution. The GR genotypes of the hematopoietic cells in reconstituted mice were confirmed by PCR of thymocyte DNA (Fig. 1a) and Southern blot (data not shown). As expected, in GRÿ/ÿ fetal liver reconstituted mice, cells of the wild-type genotype were also detected (e.g. GR+/+ stromal cells from host Ragÿ/ÿ mice that were resistant to low-dose irradiation). Nevertheless, the majority of cells from reconstituted mice were GRÿ/ÿ. The resistance of T cells from GRÿ/ÿ reconstituted mice to DEXmediated cell death also confirmed the GR status (see below). A few GRÿ/ÿ mice survive to adulthood. In experiments with adult bona fide GRÿ/ÿ mice, genotypes were also checked by PCR (Fig. 1b) . All experiments were repeated three times with reconstituted mice and confirmed with adult GRÿ/ÿ mice.
It has been reported that both DEX and anti-CD3 can upregulate GITR expression on T cells. To test whether GITR upregulation requires GR signaling, GRÿ/ÿ and GR+/+ cells were isolated and stimulated in vitro with DEX, anti-CD3, or both. From the spleens of GRÿ/ÿ and +/+ reconstituted mice, GITR-negative cells were purified by FACS sorting and cultured. Most surviving T cells in the unstimulated cultures remained GITR negative (Fig. 2a) . Stimulation with anti-CD3, with or without DEX (10 ÿ8 to 10 ÿ6 M), resulted in a dramatic increase in the percentages of both CD4 + and CD8 + GITR + T cells from both GRÿ/ÿ and +/+ mice. By 40 h, all T cells had upregulated GITR. As expected, most of the GR+/+ lymphocytes cultured with DEX alone (10 ÿ7 M) died and only a small proportion of remaining live cells had high GITR expression (data not shown). To test DEX-induced GITR upregulation further, purified CD8 + T cells (without constitutive high expression of GITR) from GR+/+ and GRÿ/ÿ adult mice were stimulated with a range of doses of DEX (10 ÿ8 to 10 ÿ6 M) or anti-CD3 (10 lg/ml). After 20 h, when a significant proportion of cells was still alive, there was no significant upregulation of GITR on live non-stimulated CD8 + T cells. While anti-CD3 antibody stimulated high levels of GITR expression on nearly all CD8 + T cells (Fig. 2b) , GC was not effective at inducing GITR upregulation. Interestingly, the intensity of GITR staining was higher on cells that had proliferated than on undivided cells in the same culture (Fig. 2c) .
T-cell death in GRÿ/ÿ mice
As GITR has been reported to function primarily as an antiapoptotic molecule, we tested whether GITR expression would render cells resistant to cell death induced by DEX and anti-CD3. Not surprisingly, DEX treatment resulted in the loss of live T cells (as well as other leukocytes) in GR+/+ mice but not in GRÿ/ÿ mice (Fig. 3a) . Upon stimulation with anti-CD3 antibody, T cells from both adult GRÿ/ÿ and +/+ mice behaved similarly. The numbers of viable cells were reduced slightly in anti-CD3 antibody stimulated cultures of both adult GRÿ/ÿ and +/+ mice, compared with those in the unstimulated cultures (Fig. 3a) . The reduction was consistent in all the experiments but not statistically significant. In GR+/+ mice, the level of cell death induced by DEX was diminished in the presence of anti-CD3 antibody on day 2 (and day 3) of culture. The presence of more viable cells after culture with both DEX and anti-CD3 antibody could not be attributed solely to anti-CD3-induced proliferation, because the proliferation at 2 days of culture was very limited, as determined by CFSE staining (data not shown).
To examine T-cell apoptosis directly, purified CD8 + T cells (without constitutive GITR expression) from adult GR+/+ and GRÿ/ÿ mice were treated with DEX and anti-CD3. Indeed, consistent with the live cell recovery in Fig. 3(a) , DEX (10 ÿ8 to 10 ÿ6 M) induced greater cell death above background (Fig. 3b) . CD8 + Tcells from GRÿ/ÿ adult mice were resistant to GC-mediated apoptosis and did not show significant death above background.
Another interesting observation was that the constitutive expression of GITR by a subset of CD4 + cells did not confer significant resistance to DEX-mediated killing. In bulk cultures of splenocytes that contained substantial numbers of CD4 cells with constitutive high GITR levels (10-20% of total CD4 cells), stimulation with DEX resulted in a dramatic loss of live cells from adult GR+/+ mice. The proportion of GITR + CD4 + T cells over GITR ÿ CD4 + T cells was not greatly changed by DEX treatment (Fig. 3c) . These findings indicated that CD4 + T cells that had constitutively high levels of GITR from GR+/+ mice had no clear survival advantage in the presence of DEX.
Cytokine production by T cells and proliferation of T cells in GRÿ/ÿ mice
We tested here the production of IFN-c and IL-2 by T cells stimulated with anti-CD3 antibody. IFN-c production was substantially suppressed by DEX in GR+/+ reconstituted splenocytes but not in GRÿ/ÿ reconstituted splenocytes (Fig. 4) . Considering that the difference in the cell numbers between anti-CD3 antibody treatment and anti-CD3 antibody / DEX treatment was not greatly different (Fig. 3a) , especially in day 2-3 cultures, the differences in cytokine production were unlikely to be due to DEX-mediated cell death, but rather due to suppression of cytokine production by T cells. Despite the fact that DEX markedly suppressed anti-CD3-induced cytokine production by GR+/+ T cells, cell proliferation was not significantly inhibited. In fact, in GR+/+ mice, anti-CD3 and DEX together can be more stimulatory than anti-CD3 alone (Fig. 5 ). For example, the numbers of divisions were consistently greater in anti-CD3 and DEX-stimulated cultures than in culture with anti-CD3 antibody alone. This was the case for both CD8 T cells and CD4 T cells. However, we cannot discount the possibility that cells that had divided further had become more resistant to DEX-mediated cell death and selectively accumulated in the cultures. As expected, in the absence of GR signaling, DEX did not inhibit T-cell proliferation by anti-CD3 antibody (Fig. 5) . T cells from GR+/+ mice proliferated to a similar extent as the cells from GRÿ/ÿ mice in the presence of 10 ÿ7 M DEX and anti-CD3 antibody. Notably, CD8 T cells proliferated faster than CD4 cells in response to anti-CD3 antibody in the same culture and cells did not proliferate without anti-CD3 antibody.
Normal development of GITR + T-cell subsets in GRÿ/ÿ mice
In both the GR+/+ and GRÿ/ÿ reconstituted mice, the proportions (% 6 SD) of GITR + CD4 + T cells of total CD4 T cells in lymph nodes were comparable (9.5 6 1.9 vs 10.1 6 1.4, respectively) (Fig. 6a) . Similar proportions of CD25 + CD4 + cells were seen in GR+/+ and GRÿ/ÿ reconstituted mice (11.5 6 1.0 vs 9.3 6 1.1, respectively) (Fig. 6a) . However, when gated CD4 + cells were plotted for expression of GITR and CD25 (Fig.  6a-iii) , only two thirds of those CD4 + cells expressing high levels of GITR expressed CD25, regardless of GR genotype. In both GR+/+ and GRÿ/ÿ reconstituted mice, CD25 6 cells/well in 1 ml in 24-well plates in medium alone, DEX (10 ÿ8 to10 ÿ6 M), anti-CD3 (10 lg/ml, immobilized) or both DEX and anti-CD3 antibody. Cells were cultured for 20 h and the plots show the data from 10 ÿ6 M DEX culture. The dashed line shows the GITR staining of unstimulated cells. (c) GITR expression on proliferated CD8+ T cells. CSFE-labeled LN cells from GR+/+ and GRÿ/ÿ reconstituted mice were cultured for 3 days as in Fig. 2(A) . Gated proliferated CD8 + T cells from anti-CD3 antibody cultures were plotted for GITR expression and CSFE profile. The mean fluorescence intensity of GITR staining of CSFE low (proliferated >2 divisions) and CSFE high unproliferated is also shown. The mean fluorescence intensity of GITR staining of unstimulated CD8 + T cells is <30 in both GR+/+ and GRÿ/ÿ mice (data not shown). mice (Fig. 6b) . Only CD4 + CD8 ÿ cells expressed appreciable levels of GITR and the percentage of GITR + CD4 + CD8 ÿ cells was comparable between the GR+/+ mice (4.8 6 0.9) and GRÿ/ÿ reconstituted mice (6.4 6 0.2). Very few cells of the other thymic subpopulations (CD4
Results from the adult GRÿ/ÿ mice were similar to those from reconstituted mice (data not shown).
Discussion
Most of the interest in GITR in T-cell biology has focused on its expression and function by regulatory T cells (particularly CD25 + CD4 + cells). Because GITR can be induced by GC signaling and TCR-mediated activation, the signaling requirement for the development of T regulatory cells has not been resolved. By using GRÿ/ÿ mice, we observed that the development of CD4 T cells (in thymic and peripheral compartments) that constitutively expressed GITR is not dependent on GR signaling. It remains to be elucidated how this subpopulation regulated their GITR expression. Enforced expression of Foxp3, a marker reported to be specific for regulatory T cells, has increased expression of GITR but not other activation markers, OX40 and CTLA-4 on CD25 ÿ CD4 + T cells and these GITR + CD25 ÿ CD4 + cells can be regulatory (18) . This suggests that the GITR expression by this subpopulation may differ from that induced by GC and classical anti-CD3 induced activation. As GITR functions mainly as an anti-apoptotic molecule, it is interesting to determine whether constitutively expressed GITR confers protection from DEXinduced cell death. A recent report shows that CD4 + CD25 + T cells (with constitutive expression of GITR) were indeed relatively resistant to cell death (19) . However, cells constitutively expressing GITR showed no clear resistance to DEXmediated cell death in our study at least at 20 h. Our data were more in line with the initial report that GITR overexpression in a CD4+ T cell line protected from TCR-induced apoptosis but not from DEX-induced cell death (6) .
A somewhat neglected aspect of GITR research is its regulation on the majority of T cells (including CD8 + and CD4 + T cells that do not have high constitutive expression of GITR) upon stimulation. Despite GITR being firstly identified to be induced by GC and activation (6), we found that a range of doses of DEX induced very limited GITR upregulation on T cells, whereas anti-CD3 induced high levels of GITR expression. Both CD4 + and CD8 + subsets from both GR+/+ and GRÿ/ÿ reconstituted mice upregulated GITR expression in response to anti-CD3 antibody. This indicates that activationinduced GITR expression is also independent of GR signaling. As mentioned above, there is compelling evidence for the role of GITR in protecting against TCR-activation induced cell death. When mice are made genetically deficient in GITR, their primary T cells become more susceptible to activationinduced cell death (8) . Moreover, over-expression of GITR in a T cell line conferred the ability to resist cell death induced by TCR-mediated activation (6) . GITR transfection however, did not protect against death induced by other stimuli like Fas triggering, UV irradiation or DEX treatment (6). Thus, it seems (from these reports and our own findings in wild-type mice) that GITR upregulation may be more important in protecting T cells against death induced by TCR activation than that from DEX treatment. How is it then that GITR upregulation during T-cell activation might protect against DEX-induced killing? There are at least two explanations. Firstly, pro-survival molecules (e.g. bcl-x) other than GITR are induced by T-cell activation (20) and these may then protect against DEXinduced death. Secondly, TCR-activation induced death pathways and steroid-induced death pathway are mutually antagonistic (2) . This second tenet would predict that in GRÿ/ÿ mice, there should be enhanced cell death from TCR activation compared with wild-type T cells. We did not find this in our experimental setting. A tentative explanation is that mature T cells, unlike T cell hybridomas (2) and immature lymphocytes (21) , are relatively resistant to anti-CD3 mediated apoptosis and thus GC-mediated protection from TCRmediated apoptosis is not absolutely required for cell survival.
Besides cell death, cytokine production and cell proliferation were also compared between GR+/+ and GRÿ/ÿ mice under stimulation of both DEX and anti-CD3 antibody. We demonstrated previously that T cells from GR+/+ and GRÿ/ÿ reconstituted mice proliferate equally to stimulation with anti-CD3 antibody (14) . Here we showed that addition of DEX at concentration of 10 ÿ7 M did not inhibit the anti-CD3 antibodyinduced proliferation of GR+/+ T cells but significantly suppressed cytokine production. At higher doses (10 ÿ6 M) of DEX, proliferation of T cells from GR+/+ but not GRÿ/ÿ reconstituted mice was suppressed (data not shown). Given that the growth factor IL-2 was greatly reduced in the presence of 10 ÿ7 M DEX, it was quite surprising that GR+/+ T cells in the co-presence of anti-CD3 antibody and DEX proliferated equally well, if not better, than cells in the absence of DEX. Not surprisingly, DEX did not affect proliferation of T cells from GRÿ/ÿ reconstituted mice. The relationship between GITR signaling and proliferation is not clear. We observed that uniform upregulation of GITR by anti-CD3-stimulated T cells occurred in the first 24 h and thus was prior to cell proliferation. However, we did observe that T cells that have divided expressed higher levels of GITR on their surface than 
